The Future of Vaccines with GSK’s Emma Walmsley

https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/7e/12/af/7e12af9b-c51e-ab10-7ea3-3e63bf3b94e8/mza_16813113319821061927.jpg/600x600bb.jpg

Changemakers

Microsoft

17 episodes

8 months ago

A transformative series co-hosted by Omar Abbosh and will.i.am.Technology is driving change in nearly every sector of business. During this era of disruption and innovation, companies must continue to reinvent and find solutions for issues facing our rapidly-evolving culture. In this series, hosts Omar Abbosh and will.i.am talk to global leaders bravely taking their organizations into the future. From groundbreaking medical advancements to renewable energy pioneers, you’ll hear stories from inspiring people at the forefront of these transformations and how they are implementing new visions forward for their businesses.

Hosted on Acast. See acast.com/privacy for more information.

All content for Changemakers is the property of Microsoft and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

The Future of Vaccines with GSK’s Emma Walmsley

Changemakers

30 minutes 56 seconds

2 years ago

The Future of Vaccines with GSK’s Emma Walmsley

The CEO of GSK (formerly GlaxoSmithKline), Dame Emma Walmsley, joins hosts Omar Abbosh and will.i.am to discuss how innovation and biotechnology are changing the future of medicine. GSK has a history of discovering game-changing medical therapies, from pharmaceuticals to consumer healthcare products. Now the global company is spinning off its consumer product business into an independent company, allowing GSK to focus fully on drug development and vaccines.

Read the transcript

Hosted on Acast. See acast.com/privacy for more information.